FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

DOJ busts ‘Greggy’s Cult’ child exploitation network that allegedly coerced kids into self-harm

Late Breaking: Trump-Endorsed Van Epps Defeats Anti-Police Democrat in TN House Race

Texas Tech restricts teaching of race and gender, faculty could be disciplined for violating rule

DOJ sues six states for refusing to turn over voter registration rolls, warns ‘open defiance’ of federal law

DOJ weighing possible new indictments for Comey and James: Reports

Trump-backed Republican keeps crucial congressional seat in GOP hands with special election victory

NYC alleged dine-and-dash influencer Pei Chung evicted from luxury apartment as she sits in jail

Illegal immigrant gang member killed police K-9 ‘Spike’ before officers returned fire in California: source

Indiana redistricting bill clears committee, heads to full House for vote

Young progressive beats out establishment candidate in Jersey City mayoral race, echoing Mamdani

GOP Rep. Elise Stefanik Says She Caught Mike Johnson Telling ‘Lies’ and Secretly ‘Siding with Jamie Raskin’

Breaking: Trump Officially Invalidates All Documents Signed by Biden Autopen, Including Pardons – Fauci, Hunter Biden Now Vulnerable

Watch: The Fieriest Trump Comments in History Just Came Out During Cabinet Meeting – POTUS Utterly Scorched Omar and Somalis, Calling Them ‘Garbage’ from ‘Stinking Country’

Pope Leo urges Trump to de-escalate tensions with Venezuela and turn to dialogue

Trump doubles down on voiding Biden autopen actions, including pardons and commutations

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”